Shire (SHPG) Interest Expense : $-532 Mil (TTM As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shire's interest expense for the three months ended in Sep. 2018 was $ -125 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2018 was $-532 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shire's Operating Income for the three months ended in Sep. 2018 was $ 1,036 Mil. Shire's Interest Expense for the three months ended in Sep. 2018 was $ -125 Mil. Shire's Interest Coverage for the quarter that ended in Sep. 2018 was 8.28. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shire Interest Expense Historical Data

The historical data trend for Shire's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Interest Expense Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Interest Expense

Get a 7-Day Free Trial

-38.10

-30.80

-41.60

-469.60

-578.90

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Interest Expense	Get a 7-Day Free Trial															-141.80	-153.50	-127.00	-125.90	-125.20

Shire Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-532 Mil.

Shire (NAS:SHPG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shire's Interest Expense for the three months ended in Sep. 2018 was $-125 Mil. Its Operating Income for the three months ended in Sep. 2018 was $1,036 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2018 was $11,098 Mil.

Shire's Interest Coverage for the quarter that ended in Sep. 2018 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2018 )	/	Interest Expense (Q: Sep. 2018 )
	=	-1	*	1036.4	/	-125.2
	=	8.28

The higher the ratio, the stronger the company's financial strength is.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085